Objective: To determine the sensitivity and specificity of thallium scintigraphy in detection of coronary artery disease in diabetic patients.
Study Design: Cross-sectional validation study.
Place And Duration Of Study: The study was carried out from July to December 2007 in the Cardiology Department of the Pakistan Institute of Medical Sciences, Islamabad.
Methodology: A total of 60 diabetic patients suspected of having coronary artery disease were studied. Systematic probability sampling technique was used during their selection. All the patients underwent thallium scintigraphy followed by coronary angiography, which was used as gold standard test.
Results: Out of 60 patients, 44 had positive thallium scintigraphy and 16 were negative. Likewise, 46 had positive angiography and 14 were negative. Out of 46 patients with positive angiography, thallium scintigraphy was positive in 41 subjects (sensitivity 89%) and false negative in only 5 of the 46 patients. Out of 14 patients with negative angiography, 11 patients had a negative thallium scintigraphy (specificity 79%) and the remaining 3 had a positive thallium scintigraphy. This gives thallium scintigraphy a positive predictive value of 93% and a negative predictive value of 69% when compared with angiography.
Conclusion: Thallium scintigraphy is a useful modality in the detection of coronary artery disease in diabetic patients.
Download full-text PDF |
Source |
---|
Mol Pharm
January 2025
Princess Margaret Cancer Centre, University Health Network, Toronto M5G 1L7, Canada.
Thallium-201 is an Auger electron-emitting radionuclide with significant potential for targeted molecular radiotherapy of cancer. It stands out among other Auger electron emitters by releasing approximately 37 Auger and Coster-Kronig electrons per decay, which is one of the highest numbers in its category. It has also a convenient half-life of 73 h, a stable daughter product, established production methods, and demonstrated high radiotoxicity.
View Article and Find Full Text PDFCurr Probl Cancer
February 2025
Department of Neurosciences, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines; Institute for Neurosciences, St. Luke's Medical Center, Quezon City & Global City, Philippines.
Background: Thallium-201 single-photon emission computed tomography (TI-SPECT) imaging has been used historically to distinguish malignant cerebral neoplasms from infectious etiologies.
Objectives: Our study aims to conduct a retrospective study, review existing literature, and perform meta-analysis on the use of TI-SPECT to differentiate malignant from non-malignant nervous system lesions when other advanced imaging modalities are not available, such as in resource-limited setting.
Methods: A retrospective study on the use of TI-SPECT in differentiating malignant versus non-malignant nervous system lesions was conducted in two tertiary hospitals in the Philippines.
J Clin Med
November 2024
Faculty of Medicine, Pasteur University Hospital, 06000 Nice, France.
J Dermatol
December 2024
Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!